Multiple Myeloma Hub

A podcast by Scientific Education Support

Categories:

54 Episodes

  1. Novel approaches in multiple myeloma: what is unique about CELMoDs?

    Published: 6/24/2020
  2. Hot topics in MM: quadruplets and anti-BCMA therapy

    Published: 6/24/2020
  3. Genomics of high-risk myeloma

    Published: 6/23/2020
  4. The association between the diversity of the oral microbiome and PFS

    Published: 6/22/2020
  5. Novel approaches in multiple myeloma: BFCR4350A

    Published: 6/18/2020
  6. Update from CARTITUDE-1 | What's new since ASH?

    Published: 6/8/2020
  7. Novel approaches in multiple myeloma: TAK-079

    Published: 6/4/2020
  8. Should we use KRd or VRd for patients with NDMM?

    Published: 6/4/2020
  9. What is the optimal treatment for bone lesions, including patients with renal insufficiency?

    Published: 6/3/2020
  10. Recent advances in our understanding of myeloma progression

    Published: 6/2/2020
  11. Quadruplet combinations in transplant-ineligible NDMM: isatuximab + Vd + cyclo or len

    Published: 6/1/2020
  12. How I treat elderly patients with NDMM

    Published: 5/28/2020
  13. Understanding resistance mechanisms to current standard of care and how to overcome them

    Published: 5/19/2020
  14. What is plasma cell leukemia and what are the latest advances in treatment?

    Published: 5/15/2020

3 / 3

Guided by an international Steering Committee of world experts in Multiple Myeloma (MM), the MM Hub is a global online resource providing key information on Multiple Myeloma for hematologists, oncologists and researchers, run in collaboration with the European School of Haematology (ESH). Our mission is to provide the latest global up-to-date clinical guidance in Multiple Myeloma, through a comprehensive coverage of evidence-based literature, drug approvals, case studies, expert opinions and international congress reports. Hosted on Acast. See acast.com/privacy for more information.